Description
AZD-8330 is an inhibitor of MEK1/2 that exhibits anticancer chemotherapeutic activity. AZD-8330 is currently in clinical trials for the treatment of advanced stage cancers.
Product Unit Size | Cost | Quantity | Stock |
---|
AZD-8330 is an inhibitor of MEK1/2 that exhibits anticancer chemotherapeutic activity. AZD-8330 is currently in clinical trials for the treatment of advanced stage cancers.
Cas No. | 869357-68-6 |
---|---|
Purity | ≥98% |
Formula | C16H17FlN3O4 |
Formula Wt. | 461.23 |
IUPAC Name | 2-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxopyridine-3-carboxamide |
Synonym | ARRY-704, ARRY-424704 |
Solubility | DMSO 92 mg/mL (199.46 mM) Ethanol 92 mg/mL (199.46 mM) Water Insoluble |
Appearance | White Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Cohen RB, Aamdal S, Nyakas M, et al. A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies. Eur J Cancer. 2013 May;49(7):1521-9. PMID: 23433846.
Akinleye A, Furqan M, Mukhi N, et al. MEK and the inhibitors: from bench to bedside. J Hematol Oncol. 2013 Apr 12;6:27. PMID: 23587417.
Prenylated phenolic terpene found in various pl...
PI3K inhibitor.
Low osmolarity contrast agent used for imaging ...
D2 and 5-HT2A antagonist.
Endogenous bombesin-related peptide, involved i...
DAT inhibitor.
Microtubule depolymerization inhibitor.
p110γ PI3K inhibitor.
α7 nAChR partial agonist, 5-HT3 antagonist.
Voltage-gated Na+ channel blocker, mAChR antago...
EGFR inhibitor.
MEK1/2 inhibitor.
Syk inhibitor.
Tuberculosis antigen
Tretinoin analog; RARα/β/γ agonist.
Dihydropyrazine found in Ligusticum walliichi. ...
Endogenous calcitonin-family peptide, involved ...
Recombinant HCV antigen fragment.
Cysteine-ITC conjugate, BITC derivative, antiox...
Isoquinoline alkaloid found in a variety of pla...